Cancer Research Annual Meeting 2010  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 4017-4025, August 1, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amberger, V. R.
Right arrow Articles by Schwab, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amberger, V. R.
Right arrow Articles by Schwab, M. E.

Characterization of a Membrane-bound Metalloendoprotease of Rat C6 Glioblastoma Cells1

Verena R. Amberger2, Paolo A. Paganetti3, Harald Seulberger4, Joyce A. Eldering and Martin E. Schwab

Brain Research Institute, University of Zurich, August-Forel-Str. 1, 8029 Zurich [V. R. A., P. A. P., H. S., M. E. S.], and Institute for Biochemistry and Molecular Biology, University of Berne, 3001 Bern [J. A. E.], Switzerland

C6 rat glioblastoma cells are able to attach to and to spread on culture dishes which are coated with purified central nervous system myelin, in contrast to normal astrocytes, fibroblasts or neuronas which adhere poorly and are unable to spread on this substrate. The metalloprotease blockers o-phenanthroline and a newly developed oligopeptide could specifically inhibit C6 cell spreading on central nervous system myelin, suggesting a crucial role for a metalloprotease. Here we characteriz this metalloproteolytic activity of C6 cells using a peptide degradation assay with the iodinated tetrapeptide carbobenzoxy-Phe-Ala-Phe-125I-Tyr-amide as a substrate. Purified, salt-washed C6 plasma membranes cleaved the peptide between alanine and phenylalanine, an effect which is strongly inhibited by o-phenanthroline, but not by thiol-blocking agents or aspartic and serine protease inhibitors. The metalloendoprotease is highly sensitive to phosphoramidon but insensitive to thiorphan. The enzyme is tightly bound to the plasma membrane but not G protein-phosphatidylinositol linked. It can be solubilized in part by the detergents 3-(3-cholamidopropyldimethylamino)-1-propanesulfonate or Triton X-114. Gel filtration chromatography using the Triton X-114-solubilized proteins or the proteins removed by a short trypsin treatment revealed a molecular weight range for the C6 enzyme of 60,000–100,000. Polymerase chain reaction with primers corresponding to endopeptidase 24.11 or to the highly conserved motif of the "astacin family" showed that both enzymes were not detectable in the C6 glioblastoma cells.

1 This study was supported by the Swiss National Science Foundation (Grant 31-29981.90), the Cancer Foundation of the Kanton of Zurich, the Slack-Gyr-Foundation (Zurich), and Regeneron Pharmaceuticals, Inc., Tarrytown, NY.

2 To whom requests for reprints should be addressed.

3 Present address: Sandoz Forschungsinstitut AG Bern, 3001 Bern, Switzerland.

4 Present address: BASF, Abteilung ZHB, 6700 Ludwigshafen, Germany.

Received 1/31/94. Accepted 5/31/94.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. M. Belcheva, P. D. Haas, Y. Tan, V. M. Heaton, and C. J. Coscia
The Fibroblast Growth Factor Receptor Is at the Site of Convergence between {micro}-Opioid Receptor and Growth Factor Signaling Pathways in Rat C6 Glioma Cells
J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 909 - 918.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. McAllister, A. E. Arbetman, S. Mandl, C. Peña-Rossi, and R. Andino
Recombinant Yellow Fever Viruses Are Effective Therapeutic Vaccines for Treatment of Murine Experimental Solid Tumors and Pulmonary Metastases
J. Virol., October 1, 2000; 74(19): 9197 - 9205.
[Abstract] [Full Text]


Home page
JCBHome page
A. T.J. Belien, P. A. Paganetti, and M. E. Schwab
Membrane-type 1 Matrix Metalloprotease (MT1-MMP) Enables Invasive Migration of Glioma Cells in Central Nervous System White Matter
J. Cell Biol., January 25, 1999; 144(2): 373 - 384.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
A. Giese, C. Hagel, E. L. Kim, S. Zapf, J. Djawaheri, M. E. Berens, and M. Westphal
Thromboxane synthase regulates the migratory phenotype of human glioma cells
Neuro-oncol, January 1, 1999; 1(1): 3 - 13.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
A. A. Spillmann, C. E. Bandtlow, F. Lottspeich, F. Keller, and M. E. Schwab
Identification and Characterization of a Bovine Neurite Growth Inhibitor (bNI-220)
J. Biol. Chem., July 24, 1998; 273(30): 19283 - 19293.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.